Alphabet Inc.
CIK 1652044 · last filed 2025-02-13
Alphabet Inc. is a corporate insider who has filed 20 SEC Form 4 insider transactions across 10 companies since 2018. Across all open-market trades the lifetime net is −$1.33B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.49B across reported positions. The firm reports its address in Mountain View, CA. 288 SEC filings were submitted jointly with Sundar Pichai.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.49B
10
20
-$1.33B
Filer Profile
MOUNTAIN VIEW, CA 94043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OSCR | 10%+ Owner | 255,092 | $34.08 | $8.69M | -$472.74M | 1 | 2023-08-21 |
| GOOGL | 10%+ Owner | 0 | $347.68 | $0 | -$52.53M | 1 | 2023-08-21 |
| PRME | 10%+ Owner | 10,229,657 | $3.23 | $33.04M | -$17.02M | 2 | 2023-06-15 |
| GTLB | 2,647,312 | $49.33 | $130.59M | $112.71M | 5 | 2023-05-09 | |
| Verve Therapeutics, Inc. (VERV) Delisted | 0 | $11.13 | $0 | -$37.17M | 1 | 2022-11-04 | |
| DUOL | 10%+ Owner | 91,565 | $153.59 | $14.06M | -$109.76M | 2 | 2022-02-10 |
| FRSH | 10%+ Owner | 2,094,204 | $12.62 | $26.44M | -$5.29M | 1 | 2021-11-23 |
| CRWD | 10%+ Owner | 9,398,840 | $236.81 | $2.23B | -$750.24M | 3 | 2020-01-03 |
| RCUS | 10%+ Owner | 1,924,474 | $24.28 | $46.73M | $0 | 1 | 2018-03-19 |
| ARMO BioSciences, Inc. (ARMO) Delisted | 10%+ Owner | 607,350 | — | — | $0 | 2 | 2018-01-30 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-13 | — | Other (J) | +167,903,168 | $0 | |
| 2023-08-21 | OSCR | Sell (S) | −58,500,000 | -$472.74M | EDGAR |
| 2023-08-21 | GOOGL | Sell (S) | −6,500,000 | -$52.53M | EDGAR |
| 2023-06-15 | PRME | Mixed | −798,840 | -$5.99M | EDGAR |
| 2023-05-12 | PRME | Sell (S) | −798,161 | -$11.03M | EDGAR |
| 2023-05-09 | GTLB | Buy (P) | +29,144 | $786.3K | EDGAR |
| 2023-03-15 | GTLB | Buy (P) | +2,556,828 | $75.95M | EDGAR |
| 2022-11-10 | GTLB | Buy (P) | +886,940 | $30.94M | EDGAR |
| 2022-11-04 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | −1,642,620 | -$37.17M | EDGAR |
| 2022-05-25 | GTLB | Buy (P) | +54,112 | $1.82M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.